The CREB-binding protein (CBP) plays a key role in the pathogenesis of tau in AD brains through its acetyltransferase activity, which is supported by the involvement of lysine acetylation of the MAPT gene in the formation of amyloid plaques [153,154]. This evidence concerns the gene MAPT and Alzheimer disease.